Related Experiment Video
Updated: Jul 14, 2026

Cell Cycle-specific Measurement of γH2AX and Apoptosis After Genotoxic Stress by Flow Cytometry
Published on: September 1, 2019
The complex role of AR signaling after cytotoxic insult: implications for cell-cycle-based chemotherapeutics
Clay E S Comstock1, Karen E Knudsen
1Department of Cell and Cancer Biology, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267, USA.
Abstract:
Prostatic adenocarcinomas are dependent on androgen receptor (AR) signaling for growth and progression, in part through the ability of AR to induce G1-S phase cell cycle transition. Hormonal therapies that inhibit AR activity are the first line of intervention for disseminated disease, and are initially quite effective; however, recurrent, incurable tumors ultimately arise with restored AR function. Given the importance of AR in governing the potentiation of this tumor type, there has been a dedicated interest in dissecting the mechanisms by which AR promotes prostate cancer proliferation and survival. Recent studies have challenged the utility of manipulating AR activity to enhance cell death in combination with genotoxic insult. Herein, the role of AR in controlling cell cycle progression and paradoxical roles of AR in survival signals are considered, as are the potential implications of these findings for chemotherapeutic response. Although there is much to be resolved, the present data suggest that knowledge of AR action in promoting cellular proliferation can be utilized for the design of coordinate strategies that maximize cell death in response to cytotoxic chemotherapeutics.
Insights
Prostate cancer growth relies on androgen receptor (AR) signaling. Understanding AR
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Prostatic adenocarcinomas depend on androgen receptor (AR) signaling for growth.
- Hormonal therapies targeting AR are initial treatments but resistance leads to tumor recurrence.
- AR's role in cell cycle progression and survival is critical in prostate cancer.
Purpose of the Study:
- To investigate the mechanisms by which AR promotes prostate cancer proliferation and survival.
- To examine the role of AR in controlling cell cycle progression.
- To consider the implications of AR's paradoxical survival roles for chemotherapeutic response.
Main Methods:
- Literature review and analysis of existing studies on AR signaling in prostate cancer.
- Examination of AR's function in cell cycle regulation (G1-S phase transition).
- Evaluation of AR's impact on cell survival pathways and response to genotoxic agents.
Main Results:
- AR signaling is crucial for G1-S phase cell cycle transition in prostate cancer.
- Recurrent tumors develop restored AR function despite initial hormonal therapy.
- AR plays paradoxical roles in survival signals, complicating therapeutic strategies.
Conclusions:
- AR's control over cell cycle progression is a key driver of prostate cancer growth.
- Understanding AR's mechanisms can inform the design of novel therapeutic strategies.
- Coordinated strategies targeting AR may enhance cell death in response to chemotherapy.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Mitogens and the Cell Cycle
